Edition:
United States

People: Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

365.00SEK
15 Nov 2018
Change (% chg)

3.00kr (+0.83%)
Prev Close
362.00kr
Open
362.50kr
Day's High
373.50kr
Day's Low
361.00kr
Volume
10,969
Avg. Vol
20,061
52-wk High
494.50kr
52-wk Low
280.00kr

Rothschild, Peter 

Mr. Peter Rothschild has been Chairman of the Board of Directors of BioGaia AB since April 25, 2018. He was Group President at the Company from March 1, 2016 till April 25, 2018. He no longer serves as Chief Executive Officer of the Company, effective as of March 1, 2016. He has held the position since 1996. He is also Founder and principal shareholder of the Company. He is Working Chairman of the subsidiaries BioGaia Production AB, BioGaia Pharma AB and CapAble AB as well as the associated company MetaboGen AB and The foundation to prevent antibiotic resistance. He also serves as Chairman of the Board of Directors of Infant Bacterial Therapeutics AB (IBT) AB and with board assignments in Glycom AB, Looft Industries AB and Stiftelsen Allbright. He holds a Master of Business Administration degree.

Basic Compensation

Total Annual Compensation, SEK 2,326,000
Restricted Stock Awards, SEK --
Long-Term Incentive Plans, SEK --
All Other, SEK --
Fiscal Year Total, SEK 2,326,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --